Company Filing History:
Years Active: 2018
Title: Ahmed Mohamed Naglah: Innovator in Pharmaceutical Chemistry
Introduction
Ahmed Mohamed Naglah is a prominent inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of novel compounds. With a total of three patents to his name, Naglah's work focuses on enhancing the efficacy of hypoglycemic agents.
Latest Patents
One of Naglah's latest patents is centered around sulfonylurea derivatives of oleanolic acid. These compounds replace the 5-chloro-2-methoxybenzoic acid moiety found in glibenclamide with oleanolic acid. The resulting triterpenoidal sulfonylurea derivatives exhibit a unique formula and are synthesized through a specific chemical process. These derivatives have been screened for their oral hypoglycemic activity in vivo, demonstrating greater potency than both glibenclamide and oleanolic acid. Another notable patent involves pentacyclic triterpenoidal derivatives, which include various compounds that show highly potent 5-lipoxygenase inhibition activity.
Career Highlights
Ahmed Mohamed Naglah is affiliated with King Saud University, where he conducts his research and development activities. His work has garnered attention for its potential applications in treating diabetes and related metabolic disorders. His innovative approach to drug development has positioned him as a key figure in pharmaceutical research.
Collaborations
Naglah has collaborated with esteemed colleagues, including Abd El-Galil E Amr and Mohamed Abdulrahman Al-Omar. These collaborations have further enriched his research endeavors and contributed to the advancement of pharmaceutical sciences.
Conclusion
Ahmed Mohamed Naglah's contributions to pharmaceutical chemistry through his innovative patents highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in the field, making a significant impact on the treatment of diabetes and related conditions.